DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ -- The global pharmaceutical supply chain is currently ...

Fashion for Good has launched Stretching Circularity, a collective initiative aimed at expediting the use of lower-impact ...

Probius to develop AI-powered point-of-care screening technology, eliminating sample preparation requirements and ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...

The Chinese manufacturer said it developed a new circuit-model–based method to accurately detect hot-spot risks in TOPCon back-contact modules, overcoming limitations of the IEC 61215 approach caused ...

Planned laboratory testing and model validation will focus on batteries, PV systems, converters, and other DC power sources.

Integration of the Xenometrix Ames mutagenicity test modernizes this cornerstone, regulatory-aligned NAM within the ...

Engineering teams can’t afford to treat AI as a hands-off solution; instead, they must learn how to balance experimentation ...

If you are glued to the Olympic coverage as I am, you are seeing the commercial from Eli Lilly and Company. Lilly's advertisement uses the scientific method as a narrative frame, drawing a par ...

"An AI system can be technically safe yet deeply untrustworthy. This distinction matters because satisfying benchmarks is necessary but insufficient for trust." ...

Subvisible particle testing addresses regulatory limits for particulate matter in parenteral drugs, ophthalmic solutions, and lipid emulsions.